Differential longitudinal decline on the mini-mental state examination in frontotemporal lobar degeneration and alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 27, Issue 4, 2013, Pages 310-315

  Tan, Kay See ^a   Libon, David J ^a   Rascovsky, Katya ^b   Grossman, Murray ^b   Xie, Sharon X ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer disease; frontotemporal lobe dementia; longitudinal assessment; MMSE

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; SEMANTIC DEMENTIA;

AGED; ALZHEIMER DISEASE; BRIEF PSYCHIATRIC RATING SCALE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SINGLE-BLIND METHOD;

EID: 84888136194     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31827bdc6f     Document Type: Article

References (35)

1. Libon DJ, Xie SX, Wang X, et al. Neuropsychological decline in frontotemporal lobe dementia: a longitudinal analysis. Neuropsychology. 2009;23:337-346.
2. Xie SX, Libon DJ, Wang X. Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer's disease. J Int Neuropsychol Soc. 2010;16: 278-286.
3. McKhann G, Trojanowski JQ, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of a work group on frontotemporal dementia and Pick's disease. Arch Neurol. 2001;58:1803-1809.
4. Knopeman DS, Jack CR Jr, Kramer JH, et al. Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology. 2009;72:1843-1849.
5. Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994;57:416-418.
6. Kramer JH, Jurik J, Sha SJ. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol. 2003;16:211-218.
7. Libon DJ, Massimo L, Moore P, et al. Screening for frontotemporal dementias and Alzheimer's disease with the Philadelphia Brief Assessment of Cognition: a preliminary analysis. Dement Geriatr Cogn Disord. 2007;24:441-447.
8. Libon DJ, Xie S, Moore P, et al. Patterns of neuropsychological impairment associated with frontotemporal dementia: a factor analytic study. Neurology. 2007;68:368-375.
9. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
10. Galasko D, Klauber MR, Hofstetter CR, et al. The Mini-Mental Examination in the early diagnosis of Alzheimer's disease. Arch Neurol. 1990;47:49-52.
11. Pasquier F, Richard F, Lebert F. Natural history of frontotemporal dementia: comparison with Alzheimer's disease. Dementia Geriatr Cogn Disord. 2004;17:253-257.
12. Rascovsky K, Salmon DP, Lipton AM, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005;65:397-403.
13. Osher J, Wicklund A, Rademaker A, et al. The Mini-Mental State Examination in behavioral variant frontotemporal dementia and primary progressive aphasia. Am J Alzheimers Dis Other Demen. 2007;22:468-473.
14. Libon DJ, Rascovsky K, Gross RG, et al. The Philadelphia Brief Assessment of Cognition (PBAC): a validated screening measure for dementia. Clin Neuropsychol. 2011;25:1314-1330.
15. Grossman M, Ash S. Primary progressive aphasia: a review. Neurocase. 2004;10:3-18.
16. Neary D, Snowden JS, Gustafson L. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
17. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006-1014.
18. Raskovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456-2477.
19. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report on the NINCDSADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
20. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974.
21. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics. 1997; 53:983-997.
22. Grossman M, Xie SX, Libon DJ, et al. Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology. 2008;70:2036-2045.
23. Grossman M, Libon DJ, Forman MS, et al. Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch Neurol. 2007;64:1601-1609.
24. Pasquier F, Lebert F, Lavenu I, et al. The clinical picture of frontotemporal dementia: diagnosis and follow-up. Dement Geriatr Cogn Disord. 1999;10(suppl 1):10-14.
25. Haxby JV, Raffaele K, Gillette J. Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J Clin Exp Neuropsychol. 1992;14:575-592.
26. Jefferson AL, Cosentino S, Ball SK, et al. Errors produced on the Mini-Mental State Examination and neuropsychological test performance among patients with Alzheimer's disease, ischaemic vascular dementia, and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2002;14:311-320.
27. Gordon E, Rohrer JD, Kim LG, et al. Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Neurology. 2010;78:666-673.
28. Rosen HJ, Narvaez JM, Hallam B, et al. Neuropsychological and functional measures of severity in Alzheimer disease, frontotemporal dementia, and semantic dementia. Alzheimer Dis Assoc Disord. 2004;18:202-207.
29. Mioshi E, Hsieh S, Savage S, et al. Clinical staging and disease progression in frontotemporal dementia. Neurology. 2010; 74:1591-1597.
30. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiologic studies of dementia. Int Psychogeriatr. 1994;6:45-56.
31. Larner AJ. Addenbrooke's Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia. Clin Neurol Neurosurg. 2007;109:491-494.
32. Mattis S. Dementia Rating Scale: Professional Manual. Odessa, FL: Psychological Assessment Resources; 1988.
33. Kipps CM, Nestor PJ, Dawson CE, et al. Measuring progression in frontotemporal dementia: implications for therapeutic interventions. Neurology. 2008;70:2046-2052.
34. Rascovsky K, Salmon DP, Hansen L, et al. Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc. 2008;14:373-383.
35. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.